Purpose

This study aims to understand the neural mechanisms that underlie synchronization of two brains during social interactions.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self reported typically developed adults.

Exclusion Criteria

  • No prior history of seizure activity. Self reported absence of recreational drugs at time of study.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Basic Science
Masking
Single (Participant)

Arm Groups

ArmDescriptionAssigned Intervention
Sham Comparator
Sham Comparator
TMS to a non-targeted region.
  • Device: Transcranial Magnetic Stimulation (TMS)
    TMS to targeted regions. Transcranial Direct Current Stimulation, tDCS, to targeted and sham regions.
Experimental
Experimental Comparator
TMS to targeted regions
  • Device: Transcranial Magnetic Stimulation (TMS)
    TMS to targeted regions. Transcranial Direct Current Stimulation, tDCS, to targeted and sham regions.

Recruiting Locations

Yale School of Medicine
New Haven, Connecticut 06511
Contact:
Joy Hirsch, PhD
9174947768
joy.hirsch@yale.edu

More Details

Status
Recruiting
Sponsor
Yale University

Study Contact

Joy Hirsch, PhD
9174947768
joy.hirsch@yale.edu

Detailed Description

After being informed about the study and potential risks, all participants giving written informed consent will undergo a structural MRI image for anatomical localization of the targeted stimulation site. Participants will be randomly assigned to one of two TMS target locations, and will be identified for the TMS experiments. Two to three days prior to the TMS experiment, participants will undergo a before TMS/fNIRS experiment. On the day of the TMS experiment participants will undergo a functional dyadic neuroimaging session after TMS stimulation. For the neuromodulation experiments, tDCS, selected sites for stimulation will be identified on the T1 anatomical scans for each participant who will be randomly assigned to one of three groups. In each case the face-gaze fNIRS experiment will be run. Aim 2: Two targeted sites will be confirmed as neural hubs by modification of fiducial neural regions based on the findings of cTBS disruptions. Rationale: These locations and functional specializations are necessary for the proposed neuromodulation tests in the upcoming clinical trial phase. Part 1: Stimulate to disrupt the site associated with eye-to-eye contact hypothesized to be right superior parietal lobule. Part 2: Stimulate to disrupt the site associated with live face gaze hypothesized to be right supramarginal gyrus. The focus of this registration is Aim 2.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.